[go: up one dir, main page]

AU2020900907A0 - Compositions and methods for the treatment of PCDH19 related disorders - Google Patents

Compositions and methods for the treatment of PCDH19 related disorders

Info

Publication number
AU2020900907A0
AU2020900907A0 AU2020900907A AU2020900907A AU2020900907A0 AU 2020900907 A0 AU2020900907 A0 AU 2020900907A0 AU 2020900907 A AU2020900907 A AU 2020900907A AU 2020900907 A AU2020900907 A AU 2020900907A AU 2020900907 A0 AU2020900907 A0 AU 2020900907A0
Authority
AU
Australia
Prior art keywords
pcdh19
compositions
treatment
methods
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020900907A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florey Institute of Neuroscience and Mental Health
Original Assignee
Florey Institute of Neuroscience and Mental Health
Filing date
Publication date
Application filed by Florey Institute of Neuroscience and Mental Health filed Critical Florey Institute of Neuroscience and Mental Health
Publication of AU2020900907A0 publication Critical patent/AU2020900907A0/en
Abandoned legal-status Critical Current

Links

AU2020900907A 2020-03-25 Compositions and methods for the treatment of PCDH19 related disorders Abandoned AU2020900907A0 (en)

Publications (1)

Publication Number Publication Date
AU2020900907A0 true AU2020900907A0 (en) 2020-04-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3890748A4 (en) Compositions and methods for the treatment of liver disorders
EP3810777A4 (en) Compositions and methods for the treatment and prevention of neurological disorders
EP4161925A4 (en) Compositions and methods for the treatment of liver disorders
EP4225923A4 (en) Compositions and methods for the prevention and/or treatment of covid-19
EP4010347A4 (en) Compositions and methods for the treatment of pain and dependance disorders
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4232458A4 (en) Compounds and methods for the treatment of ocular disorders
EP4146664A4 (en) Heterodimer compositions and methods for the treatment of ocular disorders
EP4352079A4 (en) Compositions and methods for treating neurofibromatic disorders
EP3923919A4 (en) Compositions and methods for treatment of depression and other disorders
EP4153616A4 (en) Compositions and methods for treatment of inflammatory disorders
HK40115072A (en) Compositions and methods for the treatment of pcdh19 related disorders
AU2020900907A0 (en) Compositions and methods for the treatment of PCDH19 related disorders
HK40115056A (en) Compositions and methods for the treatment of proteopathies
HK40090686A (en) Methods and compositions for the treatment of sars-cov-2
HK40075926A (en) Compositions and methods for the treatment of estrogen-dependent disorders
HK40104867A (en) Compositions and methods useful for the treatment of h-abc leukodystrophy
HK40102245A (en) Dsg2 compositions and methods for the treatment of covid-19
HK40110376A (en) Compositions and methods for treating neurofibromatic disorders
HK40108610A (en) Compositions and methods for treating neurofibromatic disorders
HK40107055A (en) Compositions and methods for the treatment of depression
HK40092945A (en) Compositions and methods for treating diseases and disorders
AU2021902146A0 (en) Compositions for the Treatment of Diseases and Conditions
HK40068687A (en) Compositions and methods for the treatment of kras associated diseases or disorders
HK40092059A (en) Compositions and methods for the treatment of synucleinopathies